2009
DOI: 10.1097/rti.0b013e31819400cc
|View full text |Cite
|
Sign up to set email alerts
|

Primary Aortic Myxofibrosarcoma Mimicking Thrombus

Abstract: Aortic sarcoma is a rare vascular malignancy. We report a case of primary aortic myxofibrosarcoma mimicking thrombus. This neoplasm demonstrated no contrast enhancement on computed tomography or magnetic resonance imaging and was clinically suspected to represent a large thrombus, although aortic primary neoplasm was considered in the differential diagnosis on the basis of imaging. Biopsies of the aortic lesion and a concurrent brain lesion were consistent with the diagnosis of aortic myxofibrosarcoma with bra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
4
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 13 publications
0
4
0
Order By: Relevance
“…Cases have been reported in the heart [34], the aorta [6] the thyroid gland [7] and the brain [2]. To the best of our knowledge, our case is the first MFS primary of the kidney to be reported.…”
Section: Discussionmentioning
confidence: 73%
“…Cases have been reported in the heart [34], the aorta [6] the thyroid gland [7] and the brain [2]. To the best of our knowledge, our case is the first MFS primary of the kidney to be reported.…”
Section: Discussionmentioning
confidence: 73%
“…The left atrium is the most common location (4), followed by the right atrium, right ventricle, and ventricular septum. A rare case of primary myxofibrosarcoma in the aorta has also been reported (5). Myxofibrosarcomas are considered to originate from myofibroblasts.…”
Section: Discussionmentioning
confidence: 99%
“…(102) Existen evidencias de una expansión más rápida del aneurisma de aorta abdominal (> 0,4 mm/año) en los pacientes fumadores. (234,235) En general, la terapéutica inicial contempla la utilización de un β-bloqueante para mantener una frecuencia cardiaca 60×' o menor y en aquellos pacientes en quienes no se logra mantener la normotensión, agregar como alternativas un inhibidor de la enzima convertidora de la angiotensina (IECA), un inhibidor de la angiotensina o un bloqueante cálcico.…”
Section: Fundamento Del Tratamiento Médico De Los Aneurismas Aórticosunclassified